Controversies in the management of pancreatic IPMN

Nature Reviews Gastroenterology and Hepatology

Volumn 8, Issue 1, 2011, Pages 56-60

  Tanaka, Masao ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARBOHYDRATE ANTIGEN; CARBOHYDRATE ANTIGEN 72-4; CARCINOEMBRYONIC ANTIGEN; K RAS PROTEIN; UNCLASSIFIED DRUG;

ASPIRATION BIOPSY; CANCER CLASSIFICATION; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FLUID ANALYSIS; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ENDOSCOPIC ECHOGRAPHY; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

ADENOCARCINOMA, MUCINOUS; CARCINOMA, PAPILLARY; CELL TRANSFORMATION, NEOPLASTIC; DIAGNOSIS, DIFFERENTIAL; HUMANS; JAPAN; NEOPLASM RECURRENCE, LOCAL; PANCREAS; PANCREATIC NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME;

EID: 78651090526     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2010.193     Document Type: Review

References (48)

1. Ohhashi, K. et al. A case of cystadenocarcinoma of the pancreas forming bilio-pancreatic fistula [Japanese]. Prog. Dig. Endosc. 17, 261-264 (1980).
2. Klöppel, G. et al. Histological Typing of Tumours of the Exocrine Pancreas, 2nd edn (springerverlag, Berlin, 1996). [series title World Health Organization International Histological Classification of Tumours].
3. Tanaka, M. et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6, 17-32 (2006).
4. Tanaka, M. Intraductal papillary mucinous neoplasm of the pancreas: diagnosis and treatment. Pancreas 28, 282-288 (2004).
5. Crippa, s. et al. Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin. Gastroenterol. Hepatol. 8, 213-219 (2010).
6. Lewandrowski, K. B., southern, J. F., Pins, M. r., Compton, C. C. & Warshaw, A. L. Cyst fluid analysis in the differential diagnosis of pancreatic cysts. A comparison of pseudocysts, serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma. Ann. Surg. 217, 41-47 (1993).
7. van der Waaij, L. A., van Dullemen, H. M. & Porte, r. J. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. Gastrointest. Endosc. 62, 383-389 (2005).
8. Linder, J. D., Geenen, J. e. & Catalano, M. F. Cyst fluid analysis obtained by eUs-guided FNA in the evaluation of discrete cystic neoplasms of the pancreas: a prospective single-center experience. Gastrointest. Endosc. 64, 697-702 (2006).
9. Attasaranya, s. et al. endoscopic ultrasoundguided fine needle aspiration and cyst fluid analysis for pancreatic cysts. JOP 8, 553-563 (2007).
10. Brugge, W. r. et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 126, 1330-1336 (2004).
11. sawhney, M. s. et al. Comparison of carcinoembryonic antigen and molecular analysis in pancreatic cyst fluid. Gastrointest. Endosc. 69, 1106-1110 (2009).
12. Leung, K. K. et al. Pancreatic cystic neoplasm: the role of cyst morphology, cyst fluid analysis, and expectant management. Ann. Surg. Oncol. 16, 2818-2824 (2009).
13. Haab, B. B. et al. Glycosylation variants of mucins and CeACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms. Ann. Surg. 251, 937-945 (2010).
14. sperti, C., Pasquali, C., Pedrazzoli, s., Guolo, P. & Liessi, G. expression of mucin-like carcinoma-associated antigen in the cyst fluid differentiates mucinous from nonmucinous pancreatic cysts. Am. J. Gastroenterol. 92, 672-675 (1997).
15. Khalid, A. et al. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointest. Endosc. 69, 1095-1102 (2009).
16. Alles, A. J., Warshaw, A. L., southern, J. F., Compton, C. C. & Lewandrowski, K. B. expression of CA 72-4 (TAG-72) in the fluid contents of pancreatic cysts. A new marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts. Ann. Surg. 219, 131-134 (1994).
17. Bernard, P. et al. Intraductal papillary-mucinous tumors of the pancreas: predictive criteria of malignancy according to pathological examination of 53 cases. Arch. Surg. 137, 1274-1278 (2002).
18. Jang, J. Y. et al. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery? Ann. Surg. Oncol. 12, 124-132 (2005).
19. schmidt, C. M. et al. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann. Surg. 246, 644-651 (2007).
20. Matsumoto, T. et al. Optimal management of the branch duct type intraductal papillary mucinous neoplasms of the pancreas. J. Clin. Gastroenterol. 36, 261-265 (2003).
21. Nagai, K. et al. Intraductal papillary mucinous neoplasms of the pancreas: clinicopathologic characteristics and long-term follow-up after resection. World J. Surg. 32, 271-278 (2008).
22. sugiyama, M. & Atomi, Y. Intraductal papillary mucinous tumors of the pancreas: imaging studies and treatment strategies. Ann. Surg. 228, 685-691 (1998).
23. rodriguez, J. r. et al. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology 133, 72-79 (2007).
24. sadakari, Y. et al. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules. Pancreas 39, 232-236 (2010).
25. Tang, r. s. et al. evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm. Clin. Gastroenterol. Hepatol. 6, 815-819 (2008).
26. salvia, r. et al. Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Gut 56, 1086-1090 (2007). (Pubitemid 47123238)
27. Nakamura, A. et al. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy. J. Pathol. 197, 201-210 (2002).
28. Furukawa, T. et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 447, 794-799 (2005).
29. Ban, s. et al. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types. Am. J. Surg. Pathol. 30, 1561-1569 (2006).
30. Ishida, M. et al. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas. Pancreas 35, 348-352 (2007).
31. sadakari, Y. et al. Invasive carcinoma derived from the nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type. Surgery 147, 812-817 (2010).
32. Hibi, Y. et al. Pancreatic juice cytology and subclassification of intraductal papillary mucinous neoplasms of the pancreas. Pancreas 34, 197-204 (2007).
33. Ohuchida, K. et al. Quantitative analysis of MUC1 and MUC5AC mrNA in pancreatic juice for preoperative diagnosis of pancreatic cancer. Int. J. Cancer 118, 405-411 (2006).
34. Kobayashi, G. et al. Mode of progression of intraductal papillary-mucinous tumor of the pancreas: analysis of patients with follow-up by eUs. J. Gastroenterol. 40, 744-751 (2005).
35. Nagai, e., Ueki, T., Chijiiwa, K., Tanaka, M. & Tsuneyoshi, M. Intraductal papillary mucinous neoplasms of the pancreas associated with so-called mucinous ductal ectasia. Histochemical and immunohistochemical analysis of 29 cases. Am. J. Surg. Pathol. 19, 576-589 (1995).
36. Tanno, s. et al. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results. Gut 57, 339-343 (2008).
37. schnelldorfer, T. et al. experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch. Surg. 143, 639-646 (2008).
38. Tanaka, M. et al. segmental balloon cytology for preoperative localization of in situ pancreatic cancer. Gastrointest. Endosc. 46, 447-449 (1997).
39. Yamaguchi, K. et al. Pancreatic cyst as a sentinel of in situ carcinoma of the pancreas. report of two cases. Int. J. Pancreatol. 22, 227-231 (1997).
40. Yamaguchi, K., Ohuchida, J., Ohtsuka, T., Nakano, K. & Tanaka, M. Intraductal papillarymucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas. Pancreatology 2, 484-490 (2002).
41. Uehara, H. et al. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Gut 57, 1561-1565 (2008).
42. Ingkakul, T. et al. Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas. Ann. Surg. 251, 70-75 (2010).
43. Kanno, A. et al. Prediction of invasive carcinoma in branch type intraductal papillary mucinous neoplasms of the pancreas. J. Gastroenterol. 45, 952-959 (2010).
44. Tanno, s. et al. Incidence of synchronous and metachronous pancreatic carcinoma in 168 patients with branch duct intraductal papillary mucinous neoplasm. Pancreatology 10, 173-178 (2010).
45. Ikeuchi, N. et al. Prognosis of cancer withbranch duct type IPMN of the pancreas. World J. Gastroenterol. 16, 1890-1895 (2010).
46. eguchi, H. et al. role of intraoperative cytology combined with histology in detecting continuous and skip type intraductal cancer existence for intraductal papillary mucinous carcinoma of the pancreas. Cancer 107, 2567-2575 (2006).
47. shi, C. et al. Increased prevalence of precursor lesions in familial pancreatic cancer patients. Clin. Cancer Res. 15, 7737-7743 (2009).
48. Poley, J. W. et al. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer. Am. J. Gastroenterol. 104, 2175-2181 (2009).